Concentra Group Holdings Parent, Inc. (CON)
NYSE:CON
US Market
Advertisement

Concentra Group Holdings Parent, Inc. (CON) AI Stock Analysis

Compare
161 Followers

Top Page

CON

Concentra Group Holdings Parent, Inc.

(NYSE:CON)

Select Model
Select Model
Select Model
Neutral 67 (OpenAI - 4o)
Rating:67Neutral
Price Target:
$21.00
▲(5.21% Upside)
Concentra Group Holdings Parent, Inc. demonstrates strong revenue growth and successful acquisition integration, which are significant positives. However, declining profit margins, negative cash flow trends, and bearish technical indicators present challenges. The stock's reasonable valuation and positive earnings call sentiment support a moderately favorable outlook.
Positive Factors
Revenue Growth
Strong revenue growth indicates robust demand and successful market penetration, enhancing long-term business sustainability and competitive positioning.
Successful Acquisition Integration
Effective integration of acquisitions demonstrates operational efficiency and strategic alignment, supporting future growth and profitability.
Adjusted EBITDA Improvement
Improved EBITDA margins reflect enhanced cost management and operational efficiency, contributing to stronger financial health and resilience.
Negative Factors
Declining Profit Margins
Decreasing profit margins indicate potential challenges in maintaining cost efficiency, which could impact long-term profitability and competitiveness.
Increased General and Administrative Expenses
Rising administrative costs can strain profitability and may require strategic adjustments to maintain financial performance and shareholder value.
Decreased Operating Cash Flow
Reduced operating cash flow may limit the company's ability to invest in growth opportunities and manage financial obligations effectively.

Concentra Group Holdings Parent, Inc. (CON) vs. SPDR S&P 500 ETF (SPY)

Concentra Group Holdings Parent, Inc. Business Overview & Revenue Model

Company DescriptionConcentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company offers occupational and consumer health services, including workers' compensation injury care, urgent care, clinical testing, preventative care, and employer services, as well as wellness programs through occupational health centers and onsite clinics. It also provides Concentra Telemed, a telemedicine solution for the treatment of work-related injuries and illnesses, and employer services; pharmacy solution under the Concentra Pharmacy name; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. The company was founded in 1979 and is based in Mechanicsburg, Pennsylvania. Concentra Group Holdings Parent, Inc. operates as a subsidiary of Select Medical Corporation.
How the Company Makes MoneyConcentra Group Holdings Parent, Inc. generates revenue through several key streams, primarily by owning and operating subsidiary companies in its diversified portfolio. These subsidiaries contribute to the company's earnings by providing products and services in their respective markets, such as technology solutions, real estate investments, and financial services. The revenue model includes direct sales from products, service contracts, and leasing income from real estate holdings. Additionally, strategic partnerships with other firms in complementary sectors help expand market reach and generate additional income through collaborative projects and joint ventures. The company's ability to leverage its resources and expertise across its sectors enhances profitability and positions it for long-term growth.

Concentra Group Holdings Parent, Inc. Earnings Call Summary

Earnings Call Date:Nov 05, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Mar 09, 2026
Earnings Call Sentiment Positive
The earnings call highlighted significant revenue growth and successful integration of recent acquisitions, contributing to a positive outlook. However, increased administrative expenses and a decline in operating cash flow and free cash flow were notable challenges.
Q3-2025 Updates
Positive Updates
Strong Revenue Growth
Concentra reported a 17% year-over-year revenue growth in Q3 2025, reaching $572.8 million, with a 10.6% increase excluding the Nova acquisition.
Increase in Patient Visits
Total patient visits increased by 9.2%, with workers' compensation visits up by 9.8% and employer services visit volumes increasing by 8.9% from the previous year.
Adjusted EBITDA Improvement
Adjusted EBITDA grew by 17.1% to $118.9 million, with the margin slightly increasing from 20.7% in Q3 2024 to 20.8% in Q3 2025.
Successful Integrations
Integration of the Nova acquisition and Pivot Onsite Innovations advanced well, with over 85% of operational and back-office synergies captured.
Positive Outlook on M&A Strategy
Company plans to continue successful acquisition strategy focusing on smaller practices with an average acquisition multiple of less than 3x EBITDA post-synergy.
Negative Updates
Increased General and Administrative Expenses
G&A expenses rose to 9.2% of revenue in Q3 2025 from 7.6% in the prior year, primarily due to public company costs and acquisition-related expenses.
Decreased Operating Cash Flow
Operating cash flow decreased from $65.9 million in Q3 2024 to $60.6 million in Q3 2025, driven largely by a $25 million increase in cash interest payments.
Free Cash Flow Decline
Free cash flow decreased from $50.8 million in Q3 2024 to $40.2 million in Q3 2025, primarily due to increased cash interest expenses and Nova integration CapEx.
Company Guidance
During Concentra Group Holdings Parent, Inc.'s third quarter 2025 earnings call, the company reported strong financial performance, with a 17% year-over-year increase in total company revenue to $572.8 million. Excluding contributions from the Nova acquisition, revenue grew by 10.6% to $541.5 million. The company also highlighted its adjusted EBITDA of $118.9 million, marking a 17.1% increase from the previous year, with an adjusted EBITDA margin slightly rising to 20.8%. Total patient visits increased by 9.2%, reaching over 55,500 visits per day. Workers' compensation visits per day grew by 9.8%, while employer services visits rose by 8.9%. Revenue per visit saw a 4.2% increase, driven by a 4.7% rise in workers' compensation and a 2.7% increase in employer services. The company also raised the lower end of its 2025 revenue guidance from $2.13 billion to $2.145 billion and adjusted EBITDA guidance from $420 million to $425 million. Concentra continues to focus on strategic growth through de novo centers, M&A, and technological investments, while aiming for a net leverage ratio of 3.5x by the end of 2025 and below 3.0x by the end of 2026.

Concentra Group Holdings Parent, Inc. Financial Statement Overview

Summary
Concentra Group Holdings Parent, Inc. shows solid revenue growth and improved leverage management. However, declining profit margins and negative free cash flow growth pose potential risks. The company needs to focus on enhancing profitability and cash flow generation to strengthen its financial position further.
Income Statement
75
Positive
Concentra Group Holdings Parent, Inc. has shown consistent revenue growth with a TTM growth rate of 4.15%. The gross profit margin has improved slightly to 28.36% in the TTM, indicating better cost management. However, the net profit margin has decreased to 7.33% from 8.76% in the previous year, reflecting a decline in profitability. The EBIT and EBITDA margins have also decreased, suggesting potential challenges in operational efficiency.
Balance Sheet
60
Neutral
The company's debt-to-equity ratio has improved significantly in the TTM to 1.39 from a high of 7.08 in the previous year, indicating better leverage management. However, the return on equity has decreased to 46.76% from 60.41%, which could be a concern for investors. The equity ratio remains stable, suggesting a balanced asset structure.
Cash Flow
65
Positive
The operating cash flow to net income ratio is strong at 0.81, indicating good cash generation relative to net income. However, the free cash flow growth rate is negative at -6.07%, which could signal potential cash flow challenges. The free cash flow to net income ratio remains healthy at 0.69, showing that the company is still generating adequate free cash flow relative to its net income.
BreakdownTTMDec 2024Dec 2023Dec 2022
Income Statement
Total Revenue2.09B1.90B1.84B1.72B
Gross Profit592.56M527.98M512.43M408.19M
EBITDA393.68M368.26M360.15M330.20M
Net Income153.24M166.54M179.95M166.73M
Balance Sheet
Total Assets2.84B2.52B2.49B2.30B
Cash, Cash Equivalents and Short-Term Investments49.94M183.25M31.37M37.66M
Total Debt2.14B1.95B905.00M1.04B
Total Liabilities2.43B2.22B1.16B1.30B
Stockholders Equity385.49M275.67M1.16B973.32M
Cash Flow
Free Cash Flow175.56M210.35M164.98M228.35M
Operating Cash Flow254.42M274.68M234.32M274.34M
Investing Cash Flow-411.41M-71.27M-75.31M-57.75M
Financing Cash Flow70.11M-51.53M-165.29M-209.86M

Concentra Group Holdings Parent, Inc. Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price19.96
Price Trends
50DMA
20.68
Negative
100DMA
20.93
Negative
200DMA
21.30
Negative
Market Momentum
MACD
-0.36
Negative
RSI
48.51
Neutral
STOCH
49.65
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CON, the sentiment is Neutral. The current price of 19.96 is above the 20-day moving average (MA) of 19.96, below the 50-day MA of 20.68, and below the 200-day MA of 21.30, indicating a neutral trend. The MACD of -0.36 indicates Negative momentum. The RSI at 48.51 is Neutral, neither overbought nor oversold. The STOCH value of 49.65 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for CON.

Concentra Group Holdings Parent, Inc. Risk Analysis

Concentra Group Holdings Parent, Inc. disclosed 62 risk factors in its most recent earnings report. Concentra Group Holdings Parent, Inc. reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Concentra Group Holdings Parent, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
$21.65B25.6510.14%1.08%8.28%97.24%
67
Neutral
$2.47B16.1846.21%1.29%
64
Neutral
$3.31B240.670.50%4.73%
60
Neutral
$1.22B-15.52-47.52%67.01%-39.19%
57
Neutral
$1.50B32.470.96%
55
Neutral
$13.29B17.4210.03%0.93%7.13%-12.93%
42
Neutral
$91.05M-706.72%
* Services Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CON
Concentra Group Holdings Parent, Inc.
19.96
-0.24
-1.19%
LH
Labcorp Holdings
266.00
30.51
12.96%
NVST
Envista Holdings
20.12
0.04
0.20%
SPAI
Safe Pro Group, Inc.
4.84
2.83
140.80%
FLOC
Flowco Holdings Inc Class A
16.72
-13.01
-43.76%
BBNX
Beta Bionics, Inc.
28.16
4.35
18.27%

Concentra Group Holdings Parent, Inc. Corporate Events

Concentra Reports Strong Q3 2025 Earnings Growth
Nov 8, 2025

Concentra Group Holdings Parent, Inc., the largest provider of occupational health services in the U.S., operates numerous health centers and clinics across the country, offering a range of services to improve workforce health.

Business Operations and StrategyStock BuybackDividendsFinancial Disclosures
Concentra Group Reports Strong Q3 2025 Financial Results
Positive
Nov 6, 2025

Concentra Group Holdings Parent, Inc. announced its third-quarter 2025 financial results, reporting a 17% increase in revenue to $572.8 million and an 8.9% rise in net income to $49.8 million compared to the same period in 2024. The company declared a cash dividend of $0.0625 per share and authorized a $100 million share repurchase program. These moves, alongside strong financial performance and strategic initiatives, position Concentra to enhance its market presence and deliver improved outcomes for stakeholders.

The most recent analyst rating on (CON) stock is a Hold with a $22.50 price target. To see the full list of analyst forecasts on Concentra Group Holdings Parent, Inc. stock, see the CON Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 10, 2025